The Orange Health Service is a public hospital located on the Bloomfield Health Campus, approximately 4 km south of the city Orange, New South Wales in Australia and is operated by Western NSW Local Health District.

There are 190 beds in Orange Health Service.

During the past decade, Orange Health Service conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orange Health Service" #1 sponsor was "BeiGene" with 2 trials, followed by "Clover Biopharmaceuticals AUS Pty Ltd" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "CStone Pharmaceuticals" with 1 trials sponsored and "Clovis Oncology, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orange Health Service" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Australia and New Zealand Dialysis and Transplant Registry" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Orange Health Service" are "Acute Myeloid Leukemia" (1 trials), "Advanced Biliary Tract Cancer" (1 trials), "Advanced Solid Tumours" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Renal Cell" (1 trials). Many other conditions were trialed in "Orange Health Service" in a lesser frequency.

Most popular intervention types in "Orange Health Service" are "Drug" (16 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "BGB-11417" (2 trials), "SCB-313" (2 trials), "ARB + DMX-200" (1 trials), "Abiraterone acetate or Enzalutamide or Docetaxel" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orange Health Service" are 15 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Orange Health Service". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Orange Health Service, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orange Health Service, 6 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".